-
-
-
-
-
-
-
Assembly Bio exercises U.S. profit-share option with Gilead for herpes program
-
-
-
-
-
-
-
Abbott wins FDA approval for dual-energy AFib ablation catheter
-
-
-
-
-
-
-
Phoenix Metals receives amended permit for Greenwood drill program
-
-
-
-
-
-
-
Pulmovant's mosliciguat hits primary endpoint in PH-ILD phase 2 trial
-
-
-
-
-
-
-
Novartis pelacarsen trial fails to meet primary endpoint
-
-
-
-
-
-
-
FDA clears software updates for Modular Medical's Pivot insulin pump
-
-
-
-
-
-
-
Ultragenyx Angelman syndrome drug fails Phase 3 trial endpoints
-
76,914 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.

